ES2664737T3 - Tratamiento de enfermedades intestinales inflamatorias con clinoptilolita - Google Patents

Tratamiento de enfermedades intestinales inflamatorias con clinoptilolita Download PDF

Info

Publication number
ES2664737T3
ES2664737T3 ES14192251.8T ES14192251T ES2664737T3 ES 2664737 T3 ES2664737 T3 ES 2664737T3 ES 14192251 T ES14192251 T ES 14192251T ES 2664737 T3 ES2664737 T3 ES 2664737T3
Authority
ES
Spain
Prior art keywords
clinoptilolite
treatment
inflammatory bowel
bowel diseases
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14192251.8T
Other languages
English (en)
Inventor
Gaston Glock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glock Health Science And Res GmbH
Glock Health Science And Research GmbH
Original Assignee
Glock Health Science And Res GmbH
Glock Health Science And Research GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glock Health Science And Res GmbH, Glock Health Science And Research GmbH filed Critical Glock Health Science And Res GmbH
Application granted granted Critical
Publication of ES2664737T3 publication Critical patent/ES2664737T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Clinoptilolita que tiene un tamaño de partícula entre 0,2 y 1 μm, para uso en el tratamiento de enfermedades intestinales inflamatorias, también denominadas EII, en animales mamíferos y seres humanos.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7

Claims (1)

  1. imagen1
ES14192251.8T 2013-11-08 2014-11-07 Tratamiento de enfermedades intestinales inflamatorias con clinoptilolita Active ES2664737T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13192094 2013-11-08
EP20130192094 EP2870967A1 (de) 2013-11-08 2013-11-08 Behandlung entzündlicher Darmerkrankungen mit Klinoptilolith

Publications (1)

Publication Number Publication Date
ES2664737T3 true ES2664737T3 (es) 2018-04-23

Family

ID=49552225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14192251.8T Active ES2664737T3 (es) 2013-11-08 2014-11-07 Tratamiento de enfermedades intestinales inflamatorias con clinoptilolita

Country Status (13)

Country Link
US (1) US9439927B2 (es)
EP (2) EP2870967A1 (es)
JP (1) JP6383643B2 (es)
KR (1) KR20150053724A (es)
CN (1) CN104622892B (es)
AU (1) AU2014259556B2 (es)
BR (1) BR102014027839A2 (es)
CA (1) CA2870270C (es)
DK (1) DK2870968T3 (es)
ES (1) ES2664737T3 (es)
HU (1) HUE036747T2 (es)
PL (1) PL2870968T3 (es)
PT (1) PT2870968T (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO758297A0 (en) * 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
CA2380941A1 (en) * 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
JP2001151681A (ja) * 1999-11-24 2001-06-05 Lintec Corp 消化器系疾患の予防および／または治療剤
DE102005053090A1 (de) * 2005-11-04 2007-05-10 Hubert Danz Verwendung eines aktivierten Zeolithen als pharmazeutisches Mittel für die Reduzierung giftiger Stoffe
WO2007054085A2 (de) * 2005-11-11 2007-05-18 Ljubicic, Mijo Antivirales mittel umfassend tribomechanisch aktiviertes zeolith (tmaz), propolis und kolostrum
SI2040837T1 (sl) 2006-07-04 2012-10-30 Gaston Glock Postopek za odločenje težkih kovin
EP2149375A1 (en) * 2008-07-28 2010-02-03 Despharma Kft. Compositions for the treatment of dermatological diseases, and uses thereof
CA2745007A1 (en) * 2008-11-28 2010-06-03 Kevin Gast Pharmaceutical compound which includes clinoptilolite

Also Published As

Publication number Publication date
CA2870270C (en) 2021-08-31
AU2014259556A1 (en) 2015-05-28
EP2870967A1 (de) 2015-05-13
PT2870968T (pt) 2018-04-13
EP2870968A1 (de) 2015-05-13
CN104622892A (zh) 2015-05-20
CA2870270A1 (en) 2015-05-08
PL2870968T3 (pl) 2018-07-31
CN104622892B (zh) 2019-03-01
US9439927B2 (en) 2016-09-13
AU2014259556B2 (en) 2019-10-24
BR102014027839A2 (pt) 2015-09-08
JP6383643B2 (ja) 2018-08-29
US20150132387A1 (en) 2015-05-14
HUE036747T2 (hu) 2018-07-30
DK2870968T3 (en) 2018-04-23
JP2015093871A (ja) 2015-05-18
EP2870968B1 (de) 2018-01-10
KR20150053724A (ko) 2015-05-18

Similar Documents

Publication Publication Date Title
CL2015002180A1 (es) Terapia de combinación para el tratamiento de neumonía nosocomial
JP2015173751A5 (es)
JP2015016294A5 (es)
ES2664737T3 (es) Tratamiento de enfermedades intestinales inflamatorias con clinoptilolita
ES2536842T3 (es) Composición farmacéutica para el tratamiento del cáncer
ES2565637T3 (es) Método de obtención de nanocristales de fluorapatita facetados
ES2629519T3 (es) Abrasivo líquido
ES2643369T3 (es) Formulación farmacéutica oral de liberación modificada que contiene gliclazida
ES2506765B1 (es) Disposición de somier tapizable
AR118561A2 (es) Anticuerpos caninizados
TH68370B (th) วิธีผลิตของแหล่งรับความร้อนและวิธีผลิตของแผ่นนำความร้อน
TH169773A (th) วิธีผลิตของแหล่งรับความร้อนและวิธีผลิตของแผ่นนำความร้อน
TWD158118S (zh) 影像投影燈具
TH127788S (th) อุปกรณ์รองรับแผ่นหลัง
TH53550S1 (th) อุปกรณ์รองรับแผ่นหลัง
ES1133330U (es) Estructura de absorción de energía para vehículos
ES1135533U (es) Silla de ruedas plegable
TH57229S1 (th) โต๊ะ
TH159566S (th) โต๊ะ
TH61973B (th) แม่พิมพ์รีดขึ้นรูปและวิธีการผลิตวัสดุขึ้นรูป
TH132002S (th) เก้าอี้
TH53109S1 (th) เก้าอี้
ES1130355U (es) Dispositivo de captación de energía solar
TH152974A (th) ฟิล์มถอดแบบ
TH62832B (th) ฟิล์มถอดแบบ